nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP2C19—urine—celiac disease	0.0966	0.134	CbGeAlD
Atomoxetine—NPY1R—pancreas—celiac disease	0.071	0.0984	CbGeAlD
Atomoxetine—HTR2A—urine—celiac disease	0.0617	0.0855	CbGeAlD
Atomoxetine—NPY1R—blood—celiac disease	0.0578	0.0801	CbGeAlD
Atomoxetine—CYP3A4—urine—celiac disease	0.0571	0.0791	CbGeAlD
Atomoxetine—CYP2D6—urine—celiac disease	0.0562	0.0778	CbGeAlD
Atomoxetine—NPY1R—liver—celiac disease	0.0452	0.0626	CbGeAlD
Atomoxetine—HTR1D—connective tissue—celiac disease	0.0345	0.0478	CbGeAlD
Atomoxetine—SLC6A3—Alpha-synuclein signaling—TOR1A—celiac disease	0.0323	0.116	CbGpPWpGaD
Atomoxetine—SLC6A4—digestive system—celiac disease	0.0234	0.0324	CbGeAlD
Atomoxetine—SLC6A4—blood—celiac disease	0.0223	0.0309	CbGeAlD
Atomoxetine—CYP2C19—digestive system—celiac disease	0.0194	0.0269	CbGeAlD
Atomoxetine—CYP2C19—blood—celiac disease	0.0185	0.0256	CbGeAlD
Atomoxetine—HTR2A—connective tissue—celiac disease	0.0171	0.0237	CbGeAlD
Atomoxetine—NPY1R—Peptide GPCRs—CCR4—celiac disease	0.0163	0.0585	CbGpPWpGaD
Atomoxetine—HTR2A—epithelium—celiac disease	0.0163	0.0225	CbGeAlD
Atomoxetine—HTR2A—smooth muscle tissue—celiac disease	0.0157	0.0217	CbGeAlD
Atomoxetine—CYP2C19—liver—celiac disease	0.0144	0.02	CbGeAlD
Atomoxetine—NPY1R—Peptide GPCRs—CCR3—celiac disease	0.0138	0.0498	CbGpPWpGaD
Atomoxetine—HTR2A—digestive system—celiac disease	0.0124	0.0171	CbGeAlD
Atomoxetine—HTR2A—blood—celiac disease	0.0118	0.0163	CbGeAlD
Atomoxetine—CYP3A4—digestive system—celiac disease	0.0115	0.0159	CbGeAlD
Atomoxetine—CYP2D6—digestive system—celiac disease	0.0113	0.0156	CbGeAlD
Atomoxetine—CYP3A4—blood—celiac disease	0.0109	0.0151	CbGeAlD
Atomoxetine—CYP2D6—blood—celiac disease	0.0107	0.0149	CbGeAlD
Atomoxetine—HTR2A—liver—celiac disease	0.00922	0.0128	CbGeAlD
Atomoxetine—CYP3A4—liver—celiac disease	0.00854	0.0118	CbGeAlD
Atomoxetine—CYP2D6—liver—celiac disease	0.0084	0.0116	CbGeAlD
Atomoxetine—NPY1R—G alpha (i) signalling events—RGS1—celiac disease	0.00836	0.03	CbGpPWpGaD
Atomoxetine—NPY1R—Peptide ligand-binding receptors—CCR4—celiac disease	0.00766	0.0275	CbGpPWpGaD
Atomoxetine—NPY1R—Peptide ligand-binding receptors—CCR3—celiac disease	0.00651	0.0234	CbGpPWpGaD
Atomoxetine—NPY1R—G alpha (i) signalling events—CCR4—celiac disease	0.00646	0.0232	CbGpPWpGaD
Atomoxetine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.006	0.0216	CbGpPWpGaD
Atomoxetine—NPY1R—G alpha (i) signalling events—CCR3—celiac disease	0.00549	0.0197	CbGpPWpGaD
Atomoxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00514	0.0185	CbGpPWpGaD
Atomoxetine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.0051	0.0183	CbGpPWpGaD
Atomoxetine—SLC6A2—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00505	0.0181	CbGpPWpGaD
Atomoxetine—SLC6A3—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00447	0.0161	CbGpPWpGaD
Atomoxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00437	0.0157	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—ARHGAP31—celiac disease	0.00393	0.0141	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR ligand binding—CCR4—celiac disease	0.00391	0.0141	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00367	0.0132	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR ligand binding—CCR3—celiac disease	0.00333	0.012	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—RGS1—celiac disease	0.00306	0.011	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—RGS1—celiac disease	0.003	0.0108	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—RGS1—celiac disease	0.00286	0.0103	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—RGS1—celiac disease	0.0026	0.00934	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00256	0.00921	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MYO9B—celiac disease	0.00238	0.00856	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—CCR4—celiac disease	0.00237	0.0085	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—CCR4—celiac disease	0.00232	0.00832	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00227	0.00816	CbGpPWpGaD
Atomoxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00221	0.00795	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—CCR4—celiac disease	0.00221	0.00795	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00221	0.00793	CbGpPWpGaD
Atomoxetine—HTR1D—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.0022	0.00789	CbGpPWpGaD
Atomoxetine—HTR1B—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00215	0.00772	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TAGAP—celiac disease	0.00207	0.00742	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—CCR3—celiac disease	0.00201	0.00723	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—CCR4—celiac disease	0.00201	0.00722	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—CCR3—celiac disease	0.00197	0.00708	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.0019	0.00681	CbGpPWpGaD
Atomoxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00188	0.00676	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00188	0.00676	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—CCR3—celiac disease	0.00188	0.00676	CbGpPWpGaD
Atomoxetine—HTR1D—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00187	0.00671	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00184	0.00662	CbGpPWpGaD
Atomoxetine—HTR1B—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00183	0.00657	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—celiac disease	0.00181	0.00651	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—CCR3—celiac disease	0.00171	0.00614	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00163	0.00585	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00161	0.00579	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.0016	0.00575	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00157	0.00563	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—RGS1—celiac disease	0.00153	0.00552	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ARHGAP31—celiac disease	0.00145	0.00521	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CCR4—celiac disease	0.00144	0.00519	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ARHGAP31—celiac disease	0.00144	0.00517	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CCR4—celiac disease	0.00143	0.00515	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00141	0.00508	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ARHGAP31—celiac disease	0.00141	0.00506	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CCR4—celiac disease	0.0014	0.00504	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.0014	0.00502	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.00139	0.00498	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CCR3—celiac disease	0.00123	0.00441	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CCR3—celiac disease	0.00122	0.00438	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00121	0.00436	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.0012	0.00432	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CCR3—celiac disease	0.00119	0.00429	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00119	0.00426	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CCR4—celiac disease	0.00119	0.00426	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL10—celiac disease	0.00109	0.00392	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ARHGAP31—celiac disease	0.00107	0.00384	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCR4—celiac disease	0.00106	0.00382	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—RGS1—celiac disease	0.00106	0.00379	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—RGS1—celiac disease	0.00105	0.00376	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00103	0.0037	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—RGS1—celiac disease	0.00103	0.00369	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CCR3—celiac disease	0.00101	0.00362	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—SH2B3—celiac disease	0.000983	0.00353	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—RGS1—celiac disease	0.000959	0.00344	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—RGS1—celiac disease	0.000951	0.00342	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—RGS1—celiac disease	0.000931	0.00335	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ARHGAP31—celiac disease	0.000927	0.00333	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCR4—celiac disease	0.000923	0.00332	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCR3—celiac disease	0.000904	0.00325	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MYO9B—celiac disease	0.000879	0.00316	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MYO9B—celiac disease	0.000872	0.00313	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MYO9B—celiac disease	0.000854	0.00307	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CCR4—celiac disease	0.000816	0.00293	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCR4—celiac disease	0.000809	0.00291	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCR4—celiac disease	0.000793	0.00285	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCR3—celiac disease	0.000785	0.00282	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—RGS1—celiac disease	0.000777	0.00279	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TAGAP—celiac disease	0.000762	0.00274	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TAGAP—celiac disease	0.000756	0.00272	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCR4—celiac disease	0.000741	0.00266	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TAGAP—celiac disease	0.00074	0.00266	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCR4—celiac disease	0.000735	0.00264	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCR4—celiac disease	0.00072	0.00259	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—RGS1—celiac disease	0.000706	0.00254	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CCR3—celiac disease	0.000694	0.00249	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCR3—celiac disease	0.000688	0.00247	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—RGS1—celiac disease	0.000675	0.00243	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCR3—celiac disease	0.000674	0.00242	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MYO9B—celiac disease	0.000647	0.00233	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCR3—celiac disease	0.00063	0.00226	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCR3—celiac disease	0.000625	0.00225	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—RGS1—celiac disease	0.000613	0.0022	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCR3—celiac disease	0.000612	0.0022	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCR4—celiac disease	0.000601	0.00216	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RGS1—celiac disease	0.000566	0.00203	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RGS1—celiac disease	0.000562	0.00202	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MYO9B—celiac disease	0.000562	0.00202	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TAGAP—celiac disease	0.000561	0.00202	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RGS1—celiac disease	0.00055	0.00198	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR4—celiac disease	0.000545	0.00196	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LCT—celiac disease	0.000542	0.00195	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR4—celiac disease	0.000522	0.00187	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCR3—celiac disease	0.000511	0.00184	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LCT—celiac disease	0.000498	0.00179	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TAGAP—celiac disease	0.000487	0.00175	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR4—celiac disease	0.000474	0.0017	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR3—celiac disease	0.000464	0.00167	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CD80—celiac disease	0.000455	0.00163	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR3—celiac disease	0.000444	0.00159	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR4—celiac disease	0.000438	0.00157	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR4—celiac disease	0.000434	0.00156	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR4—celiac disease	0.000425	0.00153	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RGS1—celiac disease	0.000417	0.0015	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR3—celiac disease	0.000403	0.00145	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR3—celiac disease	0.000372	0.00134	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR3—celiac disease	0.000369	0.00133	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SH2B3—celiac disease	0.000363	0.0013	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RGS1—celiac disease	0.000362	0.0013	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR3—celiac disease	0.000362	0.0013	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SH2B3—celiac disease	0.00036	0.00129	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SH2B3—celiac disease	0.000352	0.00127	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LCT—celiac disease	0.000326	0.00117	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR4—celiac disease	0.000322	0.00116	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR4—celiac disease	0.00028	0.00101	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR3—celiac disease	0.000274	0.000985	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SH2B3—celiac disease	0.000267	0.000959	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR3—celiac disease	0.000238	0.000855	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SH2B3—celiac disease	0.000232	0.000833	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CD80—celiac disease	0.000168	0.000603	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CD80—celiac disease	0.000166	0.000598	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CD80—celiac disease	0.000163	0.000586	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CD80—celiac disease	0.000123	0.000444	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CD80—celiac disease	0.000107	0.000385	CbGpPWpGaD
